Position in UTHR
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,779,297
+$202,719 QoQ
Shares Held
4,687
-11.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $17,208,250 across 29 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
4,687 | $2,779,297 | |
| 2 | ALKS |
Alkermes plc.
|
77,769 | $2,749,911 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
17,687 | $2,330,085 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
158,462 | $1,508,558 | |
| 5 | ZTS |
Zoetis Inc.
|
6,653 | $786,451 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
22,305 | $533,758 | |
| 7 | HLN |
Haleon plc
|
50,589 | $506,395 | |
| 8 | VTRS |
Viatris Inc
|
29,453 | $397,910 |
All Filings in UTHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,779,297 | 4,687 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,576,578 | 5,288 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,198,337 | 5,244 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,291,903 | 7,976 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,484,347 | 8,059 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,790,258 | 7,908 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,813,560 | 10,642 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,025,834 | 12,638 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,676,956 | 7,300 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,597,500 | 7,265 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,752,299 | 7,758 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,749,664 | 7,926 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,560,329 | 6,967 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,830,944 | 6,584 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,369,135 | 6,539 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,621,674 | 6,882 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,406,933 | 7,842 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,768,398 | 8,184 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,725,269 | 9,347 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,810,605 | 10,092 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,712,677 | 10,239 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,729,950 | 11,397 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $996,971 | 9,871 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,384,361 | 11,441 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $919,187 | 9,693 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||